FGCL-4592-082 (FL)

FGCL-4592-082 (FL)

A Phase 3 Randomized Double-Blind Placebo-Controlled Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients With Lower Risk Myelodysplastic Syndrome (MDS) With Low Red Blood Cell (RBC) Transfusion Burden (LTB)


Study treatments

 

Inclusion criteria


Exclusion criteria


Participating sites

Link